OmniAb, Inc. (OABI)
4.35
-0.57
(-11.59%)
USD |
NASDAQ |
Oct 06, 16:00
4.38
+0.03
(+0.69%)
Pre-Market: 08:03
OmniAb Enterprise Value : 599.37M for Oct. 6, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 06, 2026 | 599.37M |
| October 05, 2026 | 682.24M |
| October 02, 2026 | 674.97M |
| October 01, 2026 | 692.42M |
| September 30, 2026 | 688.05M |
| September 29, 2026 | 656.07M |
| September 28, 2026 | 656.07M |
| September 25, 2026 | 637.17M |
| September 24, 2026 | 663.34M |
| September 23, 2026 | 663.34M |
| September 22, 2026 | 682.24M |
| September 21, 2026 | 632.81M |
| September 18, 2026 | 616.81M |
| September 17, 2026 | 612.45M |
| September 16, 2026 | 599.37M |
| September 15, 2026 | 599.37M |
| September 14, 2026 | 618.27M |
| September 11, 2026 | 558.66M |
| September 10, 2026 | 541.21M |
| September 09, 2026 | 550.66M |
| September 08, 2026 | 583.37M |
| September 04, 2026 | 596.46M |
| September 03, 2026 | 657.52M |
| September 02, 2026 | 699.69M |
| September 01, 2026 | 612.45M |
| Date | Value |
|---|---|
| August 31, 2026 | 603.73M |
| August 28, 2026 | 616.81M |
| August 27, 2026 | 637.17M |
| August 26, 2026 | 666.25M |
| August 25, 2026 | 644.44M |
| August 24, 2026 | 651.71M |
| August 21, 2026 | 596.46M |
| August 20, 2026 | 592.10M |
| August 19, 2026 | 576.10M |
| August 18, 2026 | 536.85M |
| August 17, 2026 | 522.31M |
| August 14, 2026 | 458.34M |
| August 13, 2026 | 465.61M |
| August 12, 2026 | 464.15M |
| August 11, 2026 | 458.34M |
| August 10, 2026 | 459.79M |
| August 07, 2026 | 414.72M |
| August 06, 2026 | 292.59M |
| August 05, 2026 | 262.06M |
| August 04, 2026 | 257.70M |
| August 03, 2026 | 251.88M |
| July 31, 2026 | 254.79M |
| July 30, 2026 | 256.24M |
| July 29, 2026 | 250.43M |
| July 28, 2026 | 253.34M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| IQVIA Holdings, Inc. | 57.08B |
| Champions Oncology, Inc. | 76.91M |
| Medpace Holdings, Inc. | 16.43B |
| Charles River Laboratories International, Inc. | 17.42B |
| Avantor, Inc. | 13.83B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -5.859M |
| Revenue (Quarterly) | 13.42M |
| Total Expenses (Quarterly) | 19.27M |
| EPS Diluted (Quarterly) | -0.0455 |
| Gross Profit Margin (Quarterly) | 64.01% |
| Profit Margin (Quarterly) | -43.68% |
| Earnings Yield | -8.29% |
| Normalized Earnings Yield | -8.393 |